Log in | Register

From febrile pancytopenia to hemophagocytic lymphohistiocytosis-associated organ dysfunction

Joseph A. Carcillo| Bradley Podd| Dennis W. Simon
Understanding the Disease
Volume 43, Issue 12 / December , 2017

Pages 1853 - 1855

No abstract available.

References

  1. Creput C, Galicier L, Buyse S, Azoulay E (2008) Understanding organ dysfunction in hemophagocyticc lymphohistiocytosis. Intensive Care Med 34:1177–1187
  2. Buyse S, Teixera L, Galicier L, Mariotte E, Lemiale V, Seguion A, Bertheau P, Canet E, de Labarthe A, Darmon M, Rybjoad M, Schlemmer B, Azoulay E (2010) Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med 36:1695–1702
  3. Debaugnies F, Mahadeb B, Ferster A, Meuleman N, Rozen L, Demudder A, Corazza F (2016) Performance of the H-Score for diagnosis of hemophagocytic lymphohistiocytosis in adult and pediatric patients. Am J Clin Pathol 145:862–870
    • View reference on publisher's website
    • View reference on PubMed
  4. Demirkol D, Yildizdas D, Bayrakci B, Karapinar B, Kendirli T, Koroglu TF, Dursun O, Erkek N, Gedik H, Citak A, Kesici S, Karabocuoglu M, Carcillo JA, Turkish Secondary HLH/MAS Critical Care Study Group (2012) Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment? Crit Care 16(2):R52
    • View reference on publisher's website
    • View reference on PubMed
  5. Castillo L, Carcillo J (2009) Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med 10(3):387–392
    • View reference on publisher's website
    • View reference on PubMed
  6. Trottestam H, Horne A, Aricò M, Egeler RM, Filipovich AH, Gadner H, Imashuku S, Ladisch S, Webb D, Janka G, Henter JI, Histiocyte Society (2011) Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 118(17):4577–4584
    • View reference on publisher's website
    • View reference on PubMed
  7. Johnson TS, Terrell CE, Millen SH, Katz JD, Hildeman DA, Jordan MB (2014) Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. J Immunol 192(1):84–91
    • View reference on publisher's website
    • View reference on PubMed
  8. Pical-Izard C, Crocchiolo R, Granjeaud S, Kochbati E, Just-Landi S, Chabannon C, Frassati C, Picard C, Blaise D, Olive D, Fauriat C (2015) Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcome. Biol Blood Marrow Transpl 21(3):429–439
    • View reference on publisher's website
  9. Rey J, Fauriat C, Kochbati E, Orlanducci F, Charbonnier A, D’Incan E, Andre P, Romagne F, Barbarat B, Vey N, Olive D (2017) Kinetics of cytotoxic lymphocytes reconstitution after induction chemotherapy in elderly AML patients reveals progressive recovery of normal phenotypic and functional features in NK cells. Front Immunol 8:64
    • View reference on publisher's website
    • View reference on PubMed
  10. Minoia F, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao YJ, Huasong Z, Kitoh T, Avcin T, Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron RQ, Ravelli A, Pediatric Rheumatology International Trials Organization, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology Collaborative Study Group, Histiocyte Society (2014) Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol 66(11):3160–3169
    • View reference on publisher's website
    • View reference on PubMed
  11. Castañeda S, Blanco R, González-Gay MA (2016) Adult-onset Still’s disease: advances in the treatment. Best Pract Res Clin Rheumatol 30(2):222–238
    • View reference on publisher's website
    • View reference on PubMed
  12. Haytoglu Z, Yazici N, Erbay A (2017) Secondary hemophagocytic lymphohistiocytosis: do we really need chemotherapeutics for all patients? J Pediatr Hematol Oncol 39(2):e106–e109
    • View reference on publisher's website
    • View reference on PubMed
  13. Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, Cron RQ, Opal SM (2016) Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med 44(2):275–281
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement